Humana (HUM) | Stock Overview & Key Data
Humana Performance Comparison
Stock Range
Today's Range
Low: $239.00
High: $266.87
on October 2, 2025
52 Week Range
Low: $206.87
High: $315.35
on July 18, 2025
on September 5, 2025
All-Time High: $571.30 on October 31, 2022
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$30.6B
EPS
13.32
P/E Ratio (TTM)
18.53
Forward P/E
14.65
P/B Ratio
1.63
PEG Ratio
-0.94
Div. Yield
1.46%
ROE
9.03%
Beta
0.445
Debt to Equity
70.63
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
3.58%
Profit Margin
1.28%
Returns and Earnings
Return on Assets (TTM)
4.69%
Return on Equity (TTM)
9.03%
EBITDA
$4.0B
Net Income (TTM)
$1.6B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$1,020.46
Quarterly Revenue Growth (YoY)
9.60%
Quarterly Earnings Growth (YoY)
-19.70%
Dividend Information
Last 12-Month Dividend
$3.56
Current Dividend Yield
1.46%
3-Year Average Dividend Yield
0.23%
3-Year Average Annual Dividend
$3.46
3-Year Total Dividends
$10.38
Ex-Dividend Date
March 28, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Humana HUM | 30.56B Large-cap | 0.86% | -17.24% | 5.26% | -3.45% | 1.57% | 6.91% | -49.03% | -40.79% |
| UnitedHealth UNH | 321.15B Mega-cap | 2.36% | 14.55% | 15.01% | -32.39% | -29.89% | -40.17% | -29.94% | 7.89% |
| CVS Health CVS | 95.85B Large-cap | 3.81% | 4.54% | 16.29% | 13.78% | 75.15% | 19.91% | -12.24% | 30.39% |
| Cigna CI | 76.51B Large-cap | 4.55% | -1.24% | -7.31% | -10.53% | 8.19% | -13.09% | 2.98% | 68.36% |
| Elevance Health ELV | 71.99B Large-cap | 7.43% | 5.56% | -2.86% | -20.75% | -7.00% | -30.86% | -27.15% | 15.57% |
| Centene CNC | 17.42B Large-cap | 7.07% | 24.31% | 9.00% | -39.37% | -39.15% | -48.92% | -50.79% | -42.65% |
Ownership & Short Interest
Insider Ownership
0.21%
Institutional Ownership
96.01%
Shares Short
4M
Short Ratio
2.42
Short % of Shares Outstanding
3.81%
Average 10-Day Volume
2M
Average 90-Day Volume
2M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is HUM's 52-week high and low?
- In the last 52 weeks, Humana reached a high of $315.35 (on September 5, 2025) and a low of $206.87 (on July 18, 2025).
- What is the market cap and P/E ratio for HUM?
- Curious about Humana's size and valuation? Its market capitalization stands at 30.56B. When it comes to valuation, the P/E ratio (trailing twelve months) is 18.53, and the forward P/E (looking ahead) is 14.65.
- Does HUM pay dividends? If so, what's the yield?
- Yes, Humana is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.46%, and the company has paid an average of $3.46 per share annually over the past 3 years.
- Who are Humana's main competitors or similar companies to consider before investing?
When looking at Humana, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return UnitedHealth
UNH321.15B Healthcare Healthcare Plans -40.17% -29.94% CVS Health
CVS95.85B Healthcare Healthcare Plans 19.91% -12.24% Cigna
CI76.51B Healthcare Healthcare Plans -13.09% 2.98% Elevance Health
ELV71.99B Healthcare Healthcare Plans -30.86% -27.15% Centene
CNC17.42B Healthcare Healthcare Plans -48.92% -50.79% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Humana Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Humana's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 9.03%, the Debt to Equity ratio from the most recent quarter is 70.63, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for HUM?
- Looking at Humana's growth, its revenue over the trailing twelve months (TTM) was $123B. Compared to the same quarter last year (YoY), quarterly revenue grew by 9.60%, and quarterly earnings saw a YoY growth of -19.70%.
- How much of HUM stock is held by insiders and institutions?
- Wondering who owns Humana stock? Company insiders (like executives and directors) hold about 0.21% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 96.01%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.